GlassScriptPhysician profile
Brian T Richard
NPI 1720609068
$17,720.63
in general payments reported to CMS, 2019-2025
18 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.09 · 2022: $139 · 2023: $271 · 2024: $594 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Food and Beverage: $2,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Food and Beverage | $2,529.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2025 | |
| Acumed LLC | $5,000.00 | 2025 | |
| Stryker Corporation | $712.61 | 2025 | Variax, Pangea, Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $402.63 | 2021-2024 | Truespan Orthocord, Attune, Velys |
| Trimed, INC. | $261.07 | 2025 | |
| Bioventus LLC | $251.48 | 2023-2025 | Durolane, Bonescalpel & Sonicone (O.R.) |
| Medartis INC. | $132.18 | 2025 | Aptus |
| Skeletal Dynamics INC | $131.47 | 2024 | Align, Implate, Geminus |
| Osteocentric Technologies, INC. | $131.05 | 2022-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Vericel Corporation | $123.52 | 2022 | |
| Renerve LTD | $107.14 | 2025 | Nervalign Nerve Cuff |
| Reel Surgical, INC. | $101.42 | 2025 | |
| Smith+Nephew, INC. | $98.36 | 2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Lifenet Health | $97.07 | 2024-2025 | Allograft Vmis Delivery System, Graftlink |
| Integra Lifesciences Corporation | $71.69 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $55.84 | 2024 | Abthera Advance, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Axogen | $26.87 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Flower Orthopedics Coporation | $16.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.